Synthesis and structural characterization of tridentate [C,N,S] thiosemicarbazone palladacycles. Crystal and molecular structures of [Pd{3-FC6H3C(Me)NNC(S)NHMe}]4, [Pd{4-FC6H3C(Me)NNC(S)NHEt}]4 and [(Pd{2-BrC6H3C(Me)NNC(S)NHPh})2(μ-Ph2P(CH2)2PPh2)]

Cyclometallated Platinum(II) Complexes with Small Crown Ether Rings: Appropriate Choice of the Bridging Diphosphane to Coordinate Potassium Cations

This account reports the synthesis and structural characterization of the first cyclometallated platinum(II) complex that coordinates a potassium cation in a sandwich arrangement via two 15-crown-5 ether rings within the same molecule. The cooperation of the two small crown ether moieties allows the entrapment of the non-ideal potassium ion. The reaction of the parent thiosemicarbazone ligand 3,4-(C₈H₁₆O₅)C₆H₃C(Me)=NN-(H)C(=S)NHMe, 1, containing the crown ether ring, with K₂[PtCl₄], or alternatively with PtCl₂(DMSO)₂, and subsequent treatment with the diphosphanes Ph₂PCH₂PPh₂ (dppm) and Ph₂PC(=CH₂)PPh₂ (vdpp) produced the double nuclear platinacycles 3a, 3b, and 4, probably via formation of the 2a and 2b intermediates. Complex 3a with the K⁺ cation in a sandwich coordination was slightly mixed with 3b lacking any K⁺. Alternatively, reaction of 1 with K₂[PtCl₄] or with PtCl₂(DMSO)₂ followed by the diphosphane Ph₂PC(=CH₂)PPh₂ (vdpp) only gave the dinuclear phosphane-bridged compound 4; this highlights the importance of choosing the right diphosphane ligand. Density functional theory calculations (B3LYP-D3/LANL2DZ-ECP-6.311++G**) revealed similar affinities for both dppm and vdpp derivatives to coordinate potassium cations. Crystal structure analysis was performed for compounds 3a and 4.

Synthesis, Crystal Structure, Biological Evaluation and in Silico Studies on Novel (E)-1-(Substituted Benzylidene)-4-(3-isopropylphenyl)thiosemicarbazone Derivatives

A series of (E)-1-(substituted benzylidene)-4-(3-isopropylphenyl)thiosemicarbazone derivatives were synthesized and characterized by FT-IR spectrum, elemental analysis, NMR spectrum, HR-MS spectrum, and X-ray single crystal diffraction technology. The crystal structures and packing of (E)-1-(4-fluorobenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone and (E)-1-(3-fluorobenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone were maintained through the intramolecular hydrogen bond (N3-H6⋅⋅⋅N1) and intermolecular hydrogen bonds (N2-H4⋅⋅⋅S1, C14-H14⋅⋅⋅F1 and C7-H7⋅⋅⋅S1). The results obtained by employing the DPPH free radicals scavenging assay indicated that (E)-1-(4-methoxylbenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone had a more significant antioxidant activity compared with other compounds. The results measured by adopting the disc diffusion method elucidated that (E)-1-(4-trifluoromethylbenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone possessed a more prominent antifungal activity than other compounds. Molecular docking showed that (E)-1-(4-chlorobenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone had the highest affinity with receptor protein (1NMT). Moreover, the drug-likeness characteristic, physicochemical properties, pharmacokinetic profiles, and bioactivity scores of all the compounds were predicted through in silico studies. The results illustrated that (E)-1-(4-fluorobenzylidene)-4-(3-isopropylphenyl)thiosemicarbazone had the drug-likeness characteristic and all the compounds were considered as moderately biological active molecules.

Binuclear Ni(II) complexes containing ONS donor Schiff base ligands: Preparation, spectral characterization, X-ray crystallography and biological exploration

Four binuclear Ni(II) complexes [[Ni₂(H-DEAsal-tsc)₂(μ-dppm)]·2Cl (1), [Ni₂(DEAsal-mtsc)₂(μ-dppm)] (2), [Ni₂(DEAsal-etsc)₂(μ-dppm)] (3) and [Ni₂(DEAsal-ptsc)₂(μ-dppm)] (4)] were synthesized from the ligands namely 4(N,N)-diethylaminosalicylaldehyde-4(N)-thiosemicarbazone [H₂-DEAsal-tsc] H₂L¹/4(N,N)-diethylaminosalicylaldehyde-4(N)-methyl thiosemicarbazone [H₂-DEAsal-mtsc] H₂L²/4(N,N)-diethylaminosalicylaldehyde-4(N)-ethyl thiosemicarbazone [H₂-DEAsal-etsc] H₂L³/4(N,N)diethylaminosalicylaldehyde-4(N)-phenyl thiosemicarbazone [H₂-DEAsal-ptsc] H₂L⁴ and 1,1'-bis(diphenylphosphino)methane (dppm) and characterized by a number of spectro analytical techniques. The molecular structure of complexes [Ni₂(H-DEAsal-tsc)₂(μ-dppm)]·2Cl (1) and [Ni₂(DEAsal-ptsc)₂(μ-dppm)] (4) have been confirmed by single crystal X-ray diffraction studies. The analysis indicated that in complex 1, the ligand [H₂-DEAsal-tsc] coordinated as monobasic tridentate donor through phenolic oxygen, azomethine nitrogen and thione sulfur atoms. However, in complex 4, the ligand [H₂-DEAsal-ptsc] behaved as dibasic tridentate donor with thiolate sulfur coordination. Their ability to bind with Calf Thymus Deoxyribonucleic acid (CT-DNA) and Bovine Serum Albumin (BSA) were analysed spectrometrically. Intercalative interaction of the complexes with DNA was confirmed by ethidium bromide (EB) displacement studies and DNA viscosity measurements. The interaction mechanism of the complexes with BSA was found as static. In vitro antiproliferative studies of the ligands and complexes in A549 (human lung carcinoma cancer), MCF-7 (human breast cancer) and HeLa (human cervical cancer) cell lines witnessed significant cytotoxic nature of the complexes with low IC₅₀ values (in μM) than the standard metallo-drug cisplatin. Further, the results of Lactate Dehydrogenase (LDH) and Nitric oxide (NO) release assays supported the effectiveness of the complexes on the above said cancer cells.

New binuclear Ni(ii) metallates containing ONS chelators: synthesis, characterisation, DNA binding, DNA cleavage, protein binding, antioxidant activity, antimicrobial and in vitro cytotoxicity

Four new binuclear nickel(ii) metallates showed promising antiproliferative activity against MCF-7 and HeLa cell lines and were much less toxic against HaCaT.

Activation of C–H bonds of thiosemicarbazones by transition metals: synthesis, structures and importance of cyclometallated compounds

Transition metals (Pd^II, Pt^II, Ru^II, Rh^IIIand Ir^III) have induced activation of C–H bonds of thiosemicarbazones and yielded mono-, di-, tri- and tetra-nuclear complexes.

Synthesis and structural characterization of fluorinated thiosemicarbazones

Six new fluorinated thiosemicarbazones R-C(R′)=N-NH-C(S)NH₂ (R = 2,4-C₆H₃F₂, R′ = H (1); R = 2,5-C₆H₃F₂, R′ = H (2); R = 2,6-C₆H₃F₂, R′ = H (3); R = 3,4-C₆H₃F₂, R′ = H (4); R = 3,5-C₆H₃F₂, R′ = H (5) and R = 4-C₆H₄F, R′ = C₆H₅, (6)) have been prepared. The molecular structures of compounds 1 to 6 have been determined.